We found that the positive rate of tumour cell TUNEL staining in the BRC-treated group was significantly higher than that in the control group and that the EGR1 and p-ERK1/2 expression levels were also significantly higher in the BRC treatment group than in the control group (Fig. 8f). The gene discussed is EGR1; the disease is neoplasm.